↓ Skip to main content

Costs Associated with Febrile Neutropenia in the US

Overview of attention for article published in PharmacoEconomics, December 2012
Altmetric Badge

Citations

dimensions_citation
60 Dimensions

Readers on

mendeley
44 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Costs Associated with Febrile Neutropenia in the US
Published in
PharmacoEconomics, December 2012
DOI 10.2165/11592980-000000000-00000
Pubmed ID
Authors

Shannon L. Michels, Rich L. Barron, Matthew W. Reynolds, Karen Smoyer Tomic, Jingbo Yu, Gary H. Lyman

Abstract

Febrile neutropenia (FN) is a potentially life-threatening condition that may develop in cancer patients treated with myelosuppressive chemotherapy and result in considerable costs. This study was designed to estimate US healthcare utilization and costs in those experiencing FN by location of care, tumour type and mortality.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Korea, Republic of 1 2%
Unknown 43 98%

Demographic breakdown

Readers by professional status Count As %
Other 9 20%
Researcher 6 14%
Student > Ph. D. Student 5 11%
Student > Bachelor 3 7%
Student > Doctoral Student 2 5%
Other 8 18%
Unknown 11 25%
Readers by discipline Count As %
Medicine and Dentistry 23 52%
Agricultural and Biological Sciences 3 7%
Nursing and Health Professions 1 2%
Mathematics 1 2%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 4 9%
Unknown 11 25%